| Literature DB >> 30094304 |
Nuria Rodriguez-Garijo1, Pedro Redondo1.
Abstract
Entities:
Keywords: LBCC, linear basal cell carcinoma; eyelid surgery; linear basal cell carcinoma; musculocutaneous flap
Year: 2018 PMID: 30094304 PMCID: PMC6072646 DOI: 10.1016/j.jdcr.2018.03.001
Source DB: PubMed Journal: JAAD Case Rep ISSN: 2352-5126
Fig 1A, LBCC involving half the lower eyelid. B and C, Final defect after exeresis of the lesion with slow Mohs micrographic surgery. Drawing of a musculocutaneous transposition flap from upper eyelid. The healthy area of skin that extends from the lateral part of the lower eyelid to the external edge is included in the area to be removed. D and E, Result after removing the healthy skin's bridge and displacing the flap to the new site. F, Immediate result after suture with 6-0 silk. The donor zone closes directly. G, Appearance after 48 hours with a discrete hematoma. H, Final appearance 6 months later.
Fig 2A, LBCC located on the lower eyelid immediately below the eyelash line. B, Final defect after removal with conventional Mohs micrographic surgery. C, Design of the reconstruction using a musculocutaneous transposition flap from the upper eyelid drawn along the eyelid with a width of 1 cm. Sculpted and transposed flap, with a previous exeresis of the bridge of healthy skin next to the turning point of the tissue. D, Immediate result after suture with 6-0 silk. The donor site is directly closed by approximation. E, Appearance after 48 hours. F, Appearance after 6 months with an excellent aesthetic result and no apparent scarring.